Company intelligence / Profile preview

Millet Roux Laboratórios

Rio de Janeiro, Rio de Janeiro, Brazil

Ownership: Private
Development stage: Other

Overview

Laboratórios Millet Roux was a traditional Brazilian pharmaceutical manufacturer headquartered in Rio de Janeiro. The company was well-regarded for its portfolio of established medicines, particularly in the fields of endocrinology and dermatology. Its most recognizable product, Puran T4 (levothyroxine), remains a leading treatment for hypothyroidism in the Brazilian market. In August 2008, the company was acquired by the French pharmaceutical giant Sanofi-Aventis. This acquisition allowed Sanofi to significantly strengthen its position in the Brazilian healthcare sector and expand its offerings of branded off-patent medications.

Therapeutic areas: EndocrinologyInfectious Diseases
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Millet Roux Laboratórios.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Millet Roux Laboratórios.

Explore the full profile